RFA
SGMO

Reilly Financial Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Reilly Financial Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,000
Closed -$13K – 1069
2021
Q1 		$13K Hold
1,000
– – ﹤0.01% 643
2020
Q4 		$16K Hold
1,000
– – ﹤0.01% 538
2020
Q3 		$9K Hold
1,000
– – ﹤0.01% 595
2020
Q2 		$9K Buy
+1,000
New +$9.28K ﹤0.01% 612

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Reilly Financial Advisors's SGMO Position: Q2 2021 in Review

Reilly Financial Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2021, closing a stake of 1,000 shares — an estimated $13K sold.

Reilly Financial Advisors first reported a position in SGMO in Q2 2020 and held it in 4 quarters. The position peaked at $16K in Q4 2020. 197 funds tracked by Wall St. Rank hold SGMO as of Q2 2021.

  • Reilly Financial Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2021 after selling out during the quarter.
  • Reilly Financial Advisors sold 1,000 SANGAMO THERAPEUTICS INC shares in Q2 2021, an estimated $13K.
  • Reilly Financial Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and held it in 4 quarters.
  • Reilly Financial Advisors's SANGAMO THERAPEUTICS INC position peaked at $16K in Q4 2020.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2021.

Based on Reilly Financial Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.